M Kathleen Behrens's Net Worth

$22.8 Million

Estimate Recalculated Sep 18, 2024 12:59AM EST

Who is M Kathleen Behrens

M Kathleen Behrens has an estimated net worth of $22.8 Million. This is based on reported shares across multiple companies, which include MIMEDX GROUP, INC., Sarepta Therapeutics, Inc., IGM Biosciences, Inc., AMYLIN PHARMACEUTICALS INC, and ABGENIX INC.

SEC CIK

M Kathleen Behrens's CIK is 0001211701

Past Insider Trading and Trends

2020 was M Kathleen Behrens's most active year for acquiring shares with 18 total transactions. M Kathleen Behrens's most active month to acquire stocks was the month of February. 2006 was M Kathleen Behrens's most active year for disposing of shares, totalling 7 transactions. M Kathleen Behrens's most active month to dispose stocks was the month of March. 2016 saw M Kathleen Behrens paying a total of $1,075,275.50 for 76,500 shares, this is the most they've acquired in one year. In 2006 M Kathleen Behrens cashed out on 310,115 shares for a total of $2,252,587.50, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MIMEDX GROUP, INC.

Investor
Updated Jun 06, 2024
Form 4
14.41%
23.19K
$7.26
$168.36K
Jun 06, 2024
184.16K
Grant
Jun 05
Form 4
28.14%
35.35K
$4.95
$175.00K
Jun 15, 2023
160.97K
Grant
Jun 13
Form 4
54.27%
44.19K
$3.96
$175.00K
Jun 13, 2022
125.62K
Grant
Jun 07
Form 4
26.50%
17.06K
$10.26
$174.99K
May 28, 2021
81.43K
Grant
May 27
Form 4
68.80%
26.24K
$6.67
$174.99K
Oct 05, 2020
64.37K
Grant
Oct 02
Form 4
38.13K
Aug 06, 2020
38.14K
Grant
Aug 05
Form 3
Jun 28, 2019
Showing 7 results

Sarepta Therapeutics, Inc.

Investor
Updated Sep 05, 2024
Form 4
-0.39%
-746.00
Sep 05, 2024
201.09K
Grant
Sep 04
Form 4
$13.90
$208.50K
Jul 08, 2024
201.84K
Options
Jul 03
Form 4
3.16%
5.53K
Mar 05, 2024
190.52K
Grant
Mar 01
Form 4
$29.03
$435.45K
Nov 06, 2023
184.99K
Options
Nov 03
Form 4
3.02%
4.78K
Mar 08, 2023
173.25K
Grant
Mar 06
Form 4
$34.92
$698.40K
Dec 21, 2022
168.47K
Options
Dec 19
Form 4
5.93%
8.03K
Mar 08, 2022
153.55K
Grant
Mar 07
Form 4
$10.08
$50.40K
Dec 16, 2021
145.52K
Options
Dec 15
Form 4
-3.69%
-5.00K
$64.03
-$217.30K
Mar 10, 2021
140.52K
Sale
Mar 10
Form 4
6.45%
8.24K
Mar 05, 2021
146.04K
Grant
Mar 03
Form 4
4.58%
5.76K
Feb 28, 2020
141.43K
Grant
Feb 28
Form 4
2.03%
2.50K
$34.53
$258.95K
Sep 06, 2019
135.67K
Purchase
Sep 05 - Sep 06
Form 4
4.16%
4.85K
Mar 04, 2019
143.24K
Grant
Mar 04
Form 4
-7.90%
-10.00K
$67.84
-$1.28M
Nov 02, 2018
138.39K
Sale
Oct 31
Form 4
7.28%
8.24K
Mar 07, 2018
121.35K
Grant
Mar 05
Form 4
11.91%
13.35K
Mar 14, 2017
125.47K
Grant
Mar 10
Form 4
11.91%
13.35K
Mar 14, 2017
125.47K
Grant
Mar 10
Form 4
127.07%
75.00K
$15.54
$1.22M
Mar 16, 2016
134.02K
Purchase
Mar 14 - Mar 16
Form 4
24.91%
11.50K
Mar 02, 2016
57.67K
Grant
Feb 29
Form 4
35.42%
16.00K
Mar 03, 2015
61.17K
Grant
Feb 27
Form 4
36.23%
16.00K
Mar 04, 2014
60.17K
Grant
Feb 28
Form 4
17.26%
6.50K
$37.04
$240.78K
Sep 18, 2013
44.17K
Purchase
Sep 16
Form 4
57.27%
21.00K
Jun 06, 2013
57.67K
Grant
Jun 04
Form 4
91.31%
17.50K
$14.73
$257.72K
Sep 11, 2012
36.67K
Purchase
Sep 07
Form 4
31.82%
5.83K
Aug 27, 2012
24.17K
Grant
Aug 23
Form 4
33.33%
35.00K
Jun 22, 2011
140.00K
Grant
Jun 21
Form 4
2,000.00%
100.00K
$1.50
$150.00K
Apr 06, 2011
105.00K
Purchase
Apr 06
Form 4
35.00K
Jun 09, 2010
95.00K
Grant
Jun 08
Form 4
60.00K
Apr 02, 2009
60.00K
Grant
Mar 31
Form 3
Apr 02, 2009
Showing 30 results

IGM Biosciences, Inc.

Investor
Updated Jul 02, 2024
Form 4
30.64%
3.08K
Jul 02, 2024
403.44K
Grant
Jun 28
Form 4
44.17%
3.08K
Apr 02, 2024
400.36K
Grant
Mar 29
Form 4
29.40K
Mar 14, 2024
29.40K
Grant
Mar 12
Form 4
12.97%
800.00
Jan 03, 2024
397.28K
Grant
Dec 29
Form 4
14.90%
800.00
Oct 03, 2023
396.48K
Grant
Sep 29
Form 4
17.51%
800.00
Jul 05, 2023
395.68K
Grant
Jun 30
Form 4
51.56%
112.50K
$8.00
$900.00K
Jun 28, 2023
394.88K
Purchase
Jun 26
Form 4
15.50K
Apr 06, 2023
15.50K
Grant
Apr 04
Form 4
21.23%
800.00
Apr 04, 2023
282.38K
Grant
Mar 31
Form 4
11.02%
374.00
Jan 04, 2023
281.58K
Grant
Dec 30
Form 4
37.93%
60.00K
$17.14
$1.03M
Nov 10, 2022
281.21K
Purchase
Nov 08
Form 4
12.38%
374.00
Oct 03, 2022
221.21K
Grant
Sep 30
Form 4
14.13%
374.00
Jul 05, 2022
220.83K
Grant
Jun 30
Form 4
38.47%
61.24K
$23.00
$1.40M
Apr 04, 2022
220.46K
Purchase
Mar 31 - Apr 01
Form 4
29.50K
Mar 15, 2022
29.50K
Grant
Mar 12
Form 4
10.24%
211.00
Jan 04, 2022
159.22K
Grant
Dec 31
Form 4
11.41%
211.00
Oct 04, 2021
159.01K
Grant
Sep 30
Form 4
12.87%
211.00
Jul 02, 2021
158.79K
Grant
Jun 30
Form 4
0.22%
211.00
Apr 02, 2021
158.58K
Grant
Mar 31
Form 4
6.42K
Feb 23, 2021
6.42K
Grant
Feb 19
Form 4
0.38%
357.00
Jan 05, 2021
158.37K
Grant
Dec 31
Form 4
222.22%
44.44K
$90.00
$4.00M
Dec 15, 2020
158.02K
Purchase
Dec 11
Form 4
0.38%
357.00
Oct 05, 2020
113.57K
Grant
Oct 01
Form 4
47.46%
30.00K
$60.78
$1.82M
Sep 14, 2020
113.21K
Purchase
Sep 10
Form 4
0.57%
357.00
Jul 06, 2020
83.21K
Grant
Jul 01
Form 4
0.57%
357.00
Apr 03, 2020
82.86K
Grant
Apr 01
Form 4
10.00K
Feb 07, 2020
10.00K
Grant
Feb 05
Form 4
20.00K
$24.87
$497.32K
Dec 11, 2019
82.50K
Purchase
Dec 09
Form 4
62.50K
$16.00
$1.00M
Sep 20, 2019
62.50K
Purchase
Sep 18
Form 4
12.10K
Sep 19, 2019
12.10K
Grant
Sep 17
Form 3
Sep 17, 2019
Showing 31 results

AMYLIN PHARMACEUTICALS INC

Investor
Updated Aug 10, 2012
Form 4
-100.00%
-96.00K
$31.00
-$2.98M
Aug 10, 2012
Disposition
Aug 08
Form 4
766.67%
23.00K
May 17, 2012
26.00K
Grant
May 15
Form 4
23.00K
May 25, 2011
23.00K
Grant
May 24
Form 4
20.00K
Apr 30, 2010
20.00K
Grant
Apr 29
Form 4
30.00K
Jun 10, 2009
30.00K
Grant
Jun 09
Form 3
Jun 10, 2009
Showing 6 results

ABGENIX INC

Investor
Updated Apr 04, 2006
Form 4
-100.00%
-356.22K
$22.50
-$3.29M
Apr 04, 2006
Disposition
Apr 01
Form 4
20.00K
Jun 15, 2005
20.00K
Grant
Jun 13
Form 4
15.00K
Jun 08, 2004
15.00K
Grant
Jun 07
Form 4
Jul 01, 2003
Showing 4 results